The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer
Official Title: A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis
Study ID: NCT02066961
Brief Summary: The purpose of this study is to describe patterns in disease management and to describe clinical outcomes, as well as to identify factors influencing physician treatment decisions including reason(s) for treatment choices and trigger(s) for treatment changes and to document healthcare resource utilization used to manage treatment-related complications.
Detailed Description: Each subject will be followed from the time of enrollment for a minimum of 3 years and a maximum of up to 6 years or until death, whichever comes first.
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Site, Algiers, , Algeria
Site, Algiers, , Algeria
Site, Blida, , Algeria
Site, Buenos Aires, , Argentina
Site, Cabal, , Argentina
Site, La Pampa, , Argentina
Site, Port Macquarie, New South Wales, Australia
Site, Tweed Heads, New South Wales, Australia
Site, Kurralta Park, South Australia, Australia
Site, Parkville, Victoria, Australia
Site, Richmond, Victoria, Australia
Site, Wien, , Austria
Site, Belo Horizonte, MG, Brazil
Site, Ijuí, RS, Brazil
Site, Passo Fundo, RS, Brazil
Site, Porto Alegre, RS, Brazil
Site, São Paulo, SP, Brazil
Site, Caxias do Sul, , Brazil
Site, Santo André, , Brazil
Site, Granby, Quebec, Canada
Site, Quebec, , Canada
Site, Bogota, DC, Colombia
Site, Bogotá, DC, Colombia
Site, Cali, , Colombia
Site, Cairo, , Egypt
Site, Cairo, , Egypt
Site, Cairo, , Egypt
Site, Besançon, , France
Site, Lille, , France
Site, Nimes, , France
Site, Pierre Benite, , France
Site, Poitiers, , France
Site, Saint Mande, , France
Site, Suresnes, , France
Site, Berlin, , Germany
Site, Freiburg, , Germany
Site, Hamburg, , Germany
Site, Jena, , Germany
Site, Nürtingen, , Germany
Site, Rostock, , Germany
Site, Ulm, , Germany
Site, Jakarta, , Indonesia
Site, Beer Ya'akov, Zerifin, Israel
Site, Haifa, , Israel
Site, Brescia, , Italy
Site, Cremona, , Italy
Site, Milano, , Italy
Site, Orbassano, , Italy
Site, Anyang, , Korea, Republic of
Site, Busan, , Korea, Republic of
Site, Busan, , Korea, Republic of
Site, Incheon, , Korea, Republic of
Site, Seoul, , Korea, Republic of
Site, Seoul, , Korea, Republic of
Site, Seoul, , Korea, Republic of
Site, Suwon, , Korea, Republic of
Site, Beirut, BA, Lebanon
Site, Beirut, BA, Lebanon
Site, Durango, , Mexico
Site, Amsterdam, , Netherlands
Site, Nijmegen, , Netherlands
Site, Hamilton, Waikato, New Zealand
Site, Christchurch, , New Zealand
Site, Tauranga, , New Zealand
Site, Tauranga, , New Zealand
Site, Muscat, , Oman
Site, Miraflores, Lima, Peru
Site, Lima, , Peru
Site, Lima, , Peru
Site, Makati, , Philippines
Site, Pasig, , Philippines
Site, San Juan, , Philippines
Site, Riyadh, , Saudi Arabia
Site, Singapore, , Singapore
Site, Singapore, , Singapore
Site, Singapore, , Singapore
Site, Singapore, , Singapore
Site, Vall d'Hebron 119-129, Barcelona, Spain
Site, Madrid, , Spain
Site, Sabadell, , Spain
Site, Guishan Township, Taoyuan County, Taiwan
Site, Kaohsiung, , Taiwan
Site, Kaohsiung, , Taiwan
Site, Taichung, , Taiwan
Site, Taipei, , Taiwan
Site, Taipei, , Taiwan
Site, Bangkok, , Thailand
Site, Phayathai, , Thailand
Site, Songkla, , Thailand
Site, Hull, , United Kingdom
Site, London, , United Kingdom
Site, Newcastle upon Tyne, , United Kingdom
Site, Sunderland, , United Kingdom
Name: Senior Medical Director
Affiliation: Astellas Pharma Global Development, Inc.
Role: STUDY_DIRECTOR